|
1
|
RA Capital Management
Boston,
Massachusetts
|
$92.5M
|
–
|
–
|
–
|
|
|
2
|
Janus Henderson Group
London,
|
$89.9M
|
-$10.1M
|
-915,454
|
-9%
|
|
|
3
|
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
$86.9M
|
–
|
–
|
–
|
|
|
4
|
|
$76.9M
|
+$347K
|
+31,490
|
+0.4%
|
|
|
5
|
Vanguard Group
Malvern,
Pennsylvania
|
$72.8M
|
+$2.7M
|
+244,813
|
+3%
|
|
|
6
|
FCPM III Services
Naarden,
Netherlands
|
$52M
|
–
|
–
|
–
|
|
|
7
|
Fidelity Investments
Boston,
Massachusetts
|
$50.4M
|
+$1.08M
|
+98,075
|
+2%
|
|
|
8
|
Siren LLC
Greenwich,
Connecticut
|
$46M
|
+$23.3M
|
+2,118,450
|
+78%
|
|
|
9
|
TCG Crossover Management
Palo Alto,
California
|
$35.9M
|
+$12.3M
|
+1,116,510
|
+42%
|
|
|
10
|
State Street
Boston,
Massachusetts
|
$31.9M
|
-$2.8M
|
-253,973
|
-7%
|
|
|
11
|
Braidwell
Stamford,
Connecticut
|
$31.2M
|
-$3.83M
|
-347,995
|
-10%
|
|
|
12
|
Adage Capital Partners
Boston,
Massachusetts
|
$30.4M
|
+$35.1M
|
+3,191,000
|
New
|
|
|
13
|
|
$29.4M
|
+$6.12M
|
+555,466
|
+22%
|
|
|
14
|
Armistice Capital
New York
|
$24.4M
|
-$2.29M
|
-208,000
|
-8%
|
|
|
15
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$22.7M
|
+$6.2M
|
+563,538
|
+31%
|
|
|
16
|
Geode Capital Management
Boston,
Massachusetts
|
$21.5M
|
+$3.28M
|
+298,165
|
+15%
|
|
|
17
|
Perceptive Advisors
New York
|
$21.4M
|
-$727K
|
-66,013
|
-3%
|
|
|
18
|
|
$20.7M
|
–
|
–
|
–
|
|
|
19
|
Logos Global Management
San Francisco,
California
|
$18.1M
|
+$15.4M
|
+1,400,000
|
+280%
|
|
|
20
|
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$17.1M
|
+$6.89M
|
+625,615
|
+54%
|
|
|
21
|
|
$16.1M
|
–
|
–
|
–
|
|
|
22
|
Frazier Life Sciences Management
Palo Alto,
California
|
$14.3M
|
+$690K
|
+62,643
|
+4%
|
|
|
23
|
Saturn V Capital Management
Austin,
Texas
|
$13.9M
|
+$16M
|
+1,455,429
|
New
|
|
|
24
|
MPM BioImpact
Boston,
Massachusetts
|
$13.8M
|
+$15.9M
|
+1,446,361
|
New
|
|
|
25
|
Franklin Resources
San Mateo,
California
|
$13.2M
|
-$272K
|
-24,695
|
-2%
|
|
